GlassScriptPhysician profile
Loni M Baird
NPI 1467426148
$2,967.48
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $404 · 2022: $1,226 · 2023: $1,024 · 2024: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.46 | 2021-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $394.60 | 2021-2023 | Xifaxan |
| Janssen Biotech, INC. | $389.72 | 2021-2023 | Stelara, Simponi, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $296.77 | 2021-2024 | Entyvio, Gattex, Eohilia |
| Celgene Corporation | $220.65 | 2021-2024 | Zeposia |
| Ardelyx, INC. | $79.13 | 2022-2024 | Ibsrela |
| Intercept Pharmaceuticals, INC. | $51.75 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $49.25 | 2023-2024 | Bylvay |
| Axonics, INC. | $47.37 | 2022 | |
| Braintree Laboratories, INC. | $47.11 | 2021-2022 | |
| Pfizer INC. | $44.85 | 2023-2024 | |
| Daiichi Sankyo INC. | $41.22 | 2022 | |
| Ironwood Pharmaceuticals, INC | $38.05 | 2022-2023 | Linzess |
| Merck Sharp & Dohme LLC | $37.37 | 2022-2023 | Zinplava, Dificid |
| Genzyme Corporation | $32.30 | 2022-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $20.00 | 2022 | |
| Amgen INC. | $17.38 | 2023 | Avsola, Amjevita |
| Digestive Care, INC. | $16.56 | 2023 | Pertzye |
| Gilead Sciences, INC. | $13.29 | 2023 | |
| Redhill Biopharma INC. | $12.78 | 2021 | |
| Boston Scientific Corporation | $11.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loni Baird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.